Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab (Q35289145)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab |
scientific article |
Statements
1 reference
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab (English)
1 reference
Mario Sznol
1 reference
Jedd D Wolchok
1 reference
Sacha Gnjatic
1 reference
Achim A Jungbluth
1 reference
Gerd Ritter
1 reference
Lloyd J Old
1 reference
Katherine S Panageas
1 reference
Humilidad F Gallardo
1 reference
Stephanie L Terzulli
1 reference
Teresa S Rasalan
1 reference
Evelina Pogoriler
1 reference
Jianda Yuan
1 reference
Brian A Ginsberg
1 reference
Yinyan Xu
1 reference
Ruth Halaban
1 reference
20 September 2011
1 reference
108
1 reference
40
1 reference
16723-16728
1 reference
Identifiers
1 reference
1 reference
1 reference